EE90 Budget Impact Analysis of Introducing the Elecsys® PRO-C3 Assay as Part of the ADAPT Algorithm for Assessing the Severity of Hepatic Fibrosis in Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) in the UK
Abstract
Authors
Osvaldo Ulises Garay Bruno Golding Alessandro Pedrioli Ema Dauksaite Mark Pennington Roland Fritz